We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

DOWNLOAD THESE REPORTS NOW!

Choledocholithiasis Global Clinical Trials Review, H1, 2012

Choledocholithiasis Global Clinical Trials Review, H1, 2012

  • $ 1 000
  • Industry report
  • by Global Data
  • May 2012
  • 54 pages

Choledocholithiasis Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, ?Choledocholithiasis Global Clinical Trials Review, H1, 2012" provides data on the Choledocholithiasis clinical trial scenario. This report provides elemental information and data relating to the ...

Industries: Drug Discovery and Development | Countries: World

Eosinophilic Esophagitis Global Clinical Trials Review, H1, 2012

Eosinophilic Esophagitis Global Clinical Trials Review, H1, 2012

  • $ 1 000
  • Industry report
  • by Global Data
  • May 2012
  • 74 pages

Eosinophilic Esophagitis Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, ?Eosinophilic Esophagitis Global Clinical Trials Review, H1, 2012" provides data on the Eosinophilic Esophagitis clinical trial scenario. This report provides elemental information and data ...

Industries: Drug Discovery and Development | Countries: World, United States

Fistula Global Clinical Trials Review, H1, 2012

Fistula Global Clinical Trials Review, H1, 2012

  • $ 1 000
  • Industry report
  • by Global Data
  • May 2012
  • 73 pages

Fistula Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, ?Fistula Global Clinical Trials Review, H1, 2012" provides data on the Fistula clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fistula. It includes ...

Industries: Drug Discovery and Development | Countries: World

Lyme Disease Global Clinical Trials Review, H1, 2012

Lyme Disease Global Clinical Trials Review, H1, 2012

  • $ 1 000
  • Industry report
  • by Global Data
  • May 2012
  • 52 pages

Lyme Disease Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, ?Lyme Disease Global Clinical Trials Review, H1, 2012" provides data on the Lyme Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Lyme ...

Industries: Drug Discovery and Development | Countries: World

Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2012

Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2012

  • $ 1 000
  • Industry report
  • by Global Data
  • May 2012
  • 99 pages

Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, ?Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2012" provides data on the Non-Alcoholic Steatohepatitis clinical trial scenario. This report provides elemental information ...

Industries: Drug Discovery and Development | Countries: World, United States

Cholelithiasis Global Clinical Trials Review, H1, 2012

Cholelithiasis Global Clinical Trials Review, H1, 2012

  • $ 1 000
  • Industry report
  • by Global Data
  • May 2012
  • 70 pages

Cholelithiasis Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, ?Cholelithiasis Global Clinical Trials Review, H1, 2012" provides data on the Cholelithiasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials ...

Industries: Drug Discovery and Development | Countries: World, United States

Coronary Artery Disease (CAD) Global Clinical Trials Review, H1, 2012

Coronary Artery Disease (CAD) Global Clinical Trials Review, H1, 2012

  • $ 1 000
  • Industry report
  • by Global Data
  • May 2012
  • 122 pages

Coronary Artery Disease (CAD) Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, ?Coronary Artery Disease (CAD) Global Clinical Trials Review, H1, 2012" provides data on the Coronary Artery Disease (CAD) clinical trial scenario. This report provides elemental information ...

Industries: Drug Discovery and Development | Countries: World

Premier Research Group Limited SWOT Analysis, Strategy, Revenues and Profits

Premier Research Group Limited SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • by Global Data
  • May 2012
  • 34 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Drug Discovery and Development | Countries: Europe, United States, World

Quintiles Transnational Corp. SWOT Analysis, Strategy, Revenues and Profits

Quintiles Transnational Corp. SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • by Global Data
  • May 2012
  • 32 pages

Quintiles Transnational Corp. (Quintiles), an integrated biopharmaceutical services company, engaged in providing wide range of professional services in drug development, financial partnering and commercialization to biotechnology, pharmaceutical and healthcare companies worldwide. With a work force ...

Industries: Drug Discovery and Development | Countries: United States, Russian Federation, China, World, Indonesia

Renovo Group Plc (Symbol:RNVO) SWOT Analysis, Strategy, Revenues and Profits

Renovo Group Plc (Symbol:RNVO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • by Global Data
  • May 2012
  • 34 pages

Renovo Group Plc (Renovo) is a biopharmaceutical product development company. Founded in the year 1998, the company started its operations in the year 2000. The company focuses on the discovery and development of drugs used for enhancing tissue regeneration, improve wound healing and reduce scarring. ...

Industries: Drug Discovery and Development | Countries: World

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • 00 1 718 618 48 97

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.